Sekisui Chemical (TSE:4204) Could Be 20% Undervalued On Ausbuild Deal Review

Sekisui Chemical (TSE:4204) has called a board meeting for 10 September 2026 to review a potential acquisition of Ausbuild Group, a Queensland based residential land development and housing construction business.

The board meeting comes at a time when Sekisui Chemical’s share price has softened in the short term, with the stock down 7.61% over the past 30 days and 7.17% year to date, even as the 5 year total shareholder return of 39.38% points to a materially stronger long run record.

Scan how Sekisui Chemical compares to other construction and infrastructure plays by reviewing our curated list of solid balance sheet and fundamentals (19 results).

Sekisui Chemical looks like a solid operator with years of compounding total returns behind it, yet the recent share price pullback raises a sharper question: Is this a strong business temporarily on sale, or fairly marked already?

Most Popular Narrative: 19.9% Undervalued

On the most followed narrative, Sekisui Chemical’s last close at ¥2,484.5 sits below an estimated fair value of ¥3,100. This puts a lot of weight on its earnings path and margin story rather than the recent share price pullback.

Analyst consensus acknowledges ongoing capacity expansion for high performance plastics and mass production of perovskite solar cells. However, this may significantly understate the impact, as Sekisui is on track to become a primary supplier in next-generation mobility, electronics, and solar applications, which could drive double-digit compound annual revenue growth and materially increase group net margins over the next 3-5 years.

Read the complete narrative. Read the complete narrative.

Want to know what kind of revenue mix and margin profile needs to line up for that valuation to hold? The narrative leans on faster overseas expansion, richer product chemistry, and a future earnings base that would look very different from Sekisui Chemical’s profile today.

Result: Fair Value of ¥3,100 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, Sekisui Chemical faces clear swing factors, including pressure on its housing operations from Japan’s aging population and rising raw material and energy costs that could squeeze margins.

Find out about the key risks to this Sekisui Chemical narrative.

Another View On Sekisui Chemical’s Valuation

The first story presents Sekisui Chemical as undervalued based on future cash flows, with the share price trading 12.8% below an estimate of ¥2,848.58. A different lens tells a cooler story. On a P/E of 13.4x compared with the Asian Industrials average of 10.7x and a peer group near 12.5x, the stock appears relatively expensive, even if its fair ratio of 17.2x suggests the market could still re-rate over time. When the signals do not perfectly align, which yardstick do you rely on more?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Sentiment on Sekisui Chemical in this piece is mixed, so move quickly, review the underlying metrics yourself, and weigh both the 3 key rewards and 1 important warning sign.

Looking for more Sekisui Chemical style investment ideas?

If Sekisui Chemical has sharpened your appetite for high quality research, do not stop here. You could miss investments that better match your goals.

• Target resilient balance sheets and steady fundamentals by scanning a curated list of solid balance sheet and fundamentals (19 results) that filters out weaker financial profiles.
• Hunt for potential value opportunities before the crowd by reviewing the carefully constructed 17 high quality undervalued stocks list.
• Focus on income potential with staying power by assessing dividend-focused opportunities through the targeted 18 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com